Endocrine Surgeons Discusses Thyroid, Parathyroid, and Adrenal Care
Endocrine surgeons primarily focus on the thyroid, parathyroid, and adrenal glands. For the thyroid, their work often ...
Sun Sentinel23d
Lung cancer is the leading cause of cancer deaths here in Florida. Here’s why
“There are so many treatments.” Florida hospitals are using robots At Delray Medical Center, after a lung nodule shows up on a CT scan, specialists use a robot to biopsy it, regardless of its ...
Zacks.com on MSN5d
CORT's Dazucorilant Fails to Meet Goal in Neurologic Disorder Study
The phase II DAZALS study evaluating Corcept's dazucorilant in patients with amyotrophic lateral sclerosis fails to meet the primary goal.
Ottawa Citizen15d
Big breakthroughs for cancer patients thanks to immunotherapy treatment and research
The Ottawa Hospital is at the forefront when it comes to cancer immunotherapy research — from new therapies to clinicals ...
manilatimes9d
Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly
Paltusotine was granted Orphan Drug Designation for the treatment of acromegaly by the FDA in July 2020. This designation is ...
Hosted on MSN25d
Corcept Shares Rise More Than 60% in Three Months: Here's Why
Shares of Corcept Therapeutics Incorporated CORT have rallied 60.7% in the past three months against the industry’s decline ...
Frontiers13d
Analysis of clinical and biochemical characteristics and left ventricular hypertrophy in patients with indeterminate saline infusion test results
The remaining 23 patients received mineralocorticoid receptor antagonists (MRA) treatment according to the treatment ... imaging findings (i.e., the presence or absence of an adrenal adenoma), and ...
The Healthy on MSN15d
11 Surprising Diseases that Dermatologists Find First
But 2023 research published in the Scandinavian Journal of Gastroenterology says that once a patient begins treatment for ...
Medscape1d
‘Game Changer’ Approved for Congenital Adrenal Hyperplasia
The US Food and Drug Administration has approved crinecerfont for treating congenital CAH in combination with glucocorticoids ...
Medpage Today on MSN1d
FDA Approves First Drug for Classic Congenital Adrenal Hyperplasia in 70 Years
Crinecerfont is the first new treatment in 70 years for classic CAH and the only one that directly reduces excess ...
Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential
Neurocrine's Crenessity receives FDA approval as a groundbreaking adjunctive treatment for classic CAH, offering a novel ...